CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT

Clinical trials for CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT trials appear

Sign up with your email to follow new studies for CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists probe immune cells to predict transplant rejection

Knowledge-focused Completed

This study looked at 116 kidney transplant patients to understand how certain immune cells (B cells) contribute to organ rejection. Researchers analyzed blood samples to find patterns that might predict rejection before it happens. The goal is to improve future treatments, not to…

Matched conditions: CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT

Sponsor: University Hospital, Brest • Aim: Knowledge-focused

Last updated Jun 15, 2026 19:04 UTC

CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT

Get alerted when new CHRONIC ANTIBODY MEDIATED REJECTION (CAMR) IN KIDNEY TRANSPLANT trials appear

Scientists probe immune cells to predict transplant rejection